Stay updated on Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Added a new publication citation detailing the final KEYNOTE-826 analysis (Ann Oncol, 2025). Updated the record version to Revision: v3.6.3, replacing the previous v3.6.2.
    Difference
    0.0%
    Check dated 2026-07-06T16:38:45.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page revision label updated from v3.6.0 to v3.6.2, indicating a minor update to the page.
    Difference
    0.0%
    Check dated 2026-06-29T08:36:36.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    New help and navigation sections have been added to guide readers (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study) and the page revision updated to v3.6.0. The Intervention/Treatment header formatting was standardized and the older revision tag v3.5.5 removed.
    Difference
    0.2%
    Check dated 2026-06-15T08:34:36.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page’s revision tag was updated to v3.5.5, indicating a newer version of the page template or content. No study data or public information appears to be altered.
    Difference
    0.0%
    Check dated 2026-06-08T04:16:00.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.3 to v3.5.4, indicating a minor backend/page build change. The visible study details remain unchanged.
    Difference
    0.0%
    Check dated 2026-05-17T10:26:36.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The Taiwan study location label in the site list has been updated from 'Taoyuan District' to 'Taoyuan', providing a city-level designation for the site. This clarifies the geographic presentation of the site within the study's locations and may affect how participants find and select locations.
    Difference
    0.0%
    Check dated 2026-05-03T03:31:22.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial page.